C4 Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $33k | 5.7k | 5.70 |
| 2024-06-30 | $27k | 5.7k | 4.62 |
| 2023-03-31 | $9.3k | 3.0k | 3.14 |
| 2022-12-31 | $24k | 3.0k | 8.24 |
| 2022-09-30 | $25k | 3.0k | 8.44 |
| 2022-06-30 | $22k | 3.0k | 7.43 |
| 2022-03-31 | $72k | 3.0k | 24.31 |
| 2021-12-31 | $95k | 3.0k | 32.07 |
| 2021-09-30 | $132k | 3.0k | 44.56 |
| 2021-06-30 | $102k | 2.7k | 37.78 |
| 2021-03-31 | $33k | 894 | 36.91 |
| 2020-12-31 | $30k | 894 | 33.56 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors